Ryan Watts
Vermögen: 52 Mio $ am 31.05.2026
Vermögen: 52 Mio $ am 31.05.2026
Dr. Ryan J. Watts ist President, Chief Executive Officer & Director bei Denali Therapeutics, Inc. Er ist Mitglied des Board of Directors von Denali Therapeutics, Inc. Dr. Watts war zuvor als Director-Neuroscience Department bei Genentech, Inc. beschäftigt. Er erhielt seinen Bachelor-Abschluss von der University of Utah und einen Doktortitel von der Stanford University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 2’449’437 ( 1.54% ) | 52 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DENALI THERAPEUTICS INC. | Gründer | 14.10.2013 |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | 23.02.2023 |
Rippl Care, Inc.
Rippl Care, Inc. Internet Software/ServicesTechnology Services Operates as a care platform that helps senior living with dementia remain at home and out of the emergency department and hospitals | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Gründer | 01.02.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Rippl Care, Inc.
Rippl Care, Inc. Internet Software/ServicesTechnology Services Operates as a care platform that helps senior living with dementia remain at home and out of the emergency department and hospitals | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen